Assistant Vice President (Biotechnology Public Equity)
Nan Fung Group
About this role
Nan Fung Life Sciences / Pivotal Life Sciences is hiring for a public equity investing role within the Group CEO’s Office focused on biotech companies listed in the U.S. and Hong Kong. The position supports investment decision-making by analyzing scientific data, market trends, and clinical developments to inform the firm’s public equity investments.
Skills
Qualifications
About Nan Fung Group
nanfung.comFounded in 1954, Nan Fung Group are a privately-held conglomerate headquartered in Hong Kong. With a deeply rooted presence in the city, our eyes are set on the international stage with diversified businesses and investments all over the world.
Recent company news
PR NewswireNan Fung Group Advances SEWIT Sustainability Framework as Business Strategy, Delivering Greater Impact to Tenants and Corporate Partners
Nov 8, 2025
Bloomberg.comFamily Office NF Trinity to Expand in US With New York Presence
May 7, 2025
DBSDBS Hong Kong and Nan Fung Group sign a bilateral HKD 1,500 million multi-currency sustainability-linked loan
Nov 17, 2025
The Standard (HK)Nan Fung Group’s youngest daughter sues sister over alleged improper transfer of multi-billion estate
1 month ago
ArupArup supports Nan Fung Group in strategic decarbonisation
Mar 27, 2025
About Nan Fung Group
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Nan Fung Group.
Salary
$139k – $188k
per year
More jobs at Nan Fung Group
Similar Jobs
Senior Analyst, Private Equity Investments
Fidelity
Equity Research Analyst
Infini Capital Management Limited
Equity Research Associate, Smid Biotechnology
FlyFlat
Front Office Equity Derivatives Quant, Vice President
Barclays
Equity Research Associate – Biotechnology
BMO
Investment Analyst, Private Equity Asia
Manulife